XML 27 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Financial Information
12 Months Ended
Mar. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Financial Information

Quarterly Results of Operations (Unaudited)

 

The following table presents the unaudited statements of operations data for each of the eight quarters in the period ended March 31, 2013.  This information represents the activity of VistaGen California for the pre-Merger portion of the first quarter of fiscal 2012 and the consolidated activity of VistaGen California and the Company from May 11, 2011 (the date of the Merger) through March 31, 2013. A total of 1,569,000 shares of common stock, representing the 784,500 shares held by stockholders of Excaliber immediately prior to the Merger and effected for the post-Merger two-for-one (2:1) stock split described in Note 1, Description of Business, have been retroactively reflected as outstanding for the entire fiscal year ended March 31, 2012 for purposes of determining basic and diluted loss per common share below.

 

The information has been presented on the same basis as the audited financial statements and all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts below to present fairly the unaudited quarterly results when read in conjunction with the audited financial statements and related notes. The operating results for any quarter should not be relied upon as necessarily indicative of results for any future period.

 

Unaudited Quarterly Results of Operations

(in thousands, except share and per share amounts)

 

 

    Three Months Ended        
   

June 30,

2012

   

September 30,

2012

   

December 31,

2012

   

March 31,

2013

   

Total Fiscal Year

2013

 
                               
Revenues:                              
    Grant revenue   $ 200     $     $     $     $ 200  
    Total revenues     200                         200  
Operating expenses:                                        
    Research and development     866       1,106       1,120       339       3,431  
    General and administrative     1,055       576       799       1,132       3,562  
    Total operating expenses     1,921       1,682       1,919       1,471       6,993  
Loss from operations     (1,721 )     (1,682 )     (1,919 )     (1,471 )     (6,793 )
Other expenses, net:                                        
    Interest expense, net     (103 )     (274 )     (235 )     (309 )     (921 )
    Change in put and note extension option and warrant liabilities                 358       (1,994 )     (1,636 )
    Loss on early extinguishment of debt                 (3,537 )     (31 )     (3,568 )
    Other income                 -       35       35  
    Loss before income taxes     (1,824 )     (1,956 )     (5,333 )     (3,770 )     (12,883 )
    Income taxes     (2 )           (2 )           (4 )
    Net loss     (1,826 )     (1,956 )     (5,335 )     (3,770 )     (12,887 )
        Deemed dividend on Series A Preferred Stock     -               (10,193 )             (10,193 )
    Net loss attributable to common stockholders   $ (1,826 )   $ (1,956 )   $ (15,528 )   $ (3,770 )   $ (23,080 )
    Basic and diluted net loss per common share   $ (0.11 )   $ (0.11 )   $ (0.85 )   $ (0.19 )   $ (1.27 )
    Weighted average shares used in computing basic and diluted net loss per common share     16,842,655       17,094,833       18,292,301       20,236,491       18,108,444  

 

Note:  reflects adjustment to amount of deemed dividend on Series A Preferred Stock in the quarter ended December 31, 2012.

 

    Three Months Ended        
   

June 30,

2011

   

September 30,

2011

   

December 31,

2011

   

March 31,

2012

   

Total Fiscal Year

2012

 
                               
Revenues:                              
    Grant revenue   $ 555     $ 316     $ 2     $ 469     $ 1,342  
    Total revenues     555       316       2       469       1,342  
Operating expenses:                                        
    Research and development     1,028       (1,227 )     1,306       1,828       5,389  
    General and administrative     1,127       894       1,548       1,428       4,997  
    Total operating expenses     2,155       2,121       2,854       3,256       10,386  
Loss from operations     (1,600 )     (1,805 )     (2,852 )     (2,787 )     (9,044 )
Other expenses, net:                                        
    Interest expense, net     (731 )     (451 )     (455 )     (256 )     (1,893 )
    Change in put and note extension option and warrant liabilities     (78 )                       (78 )
    Loss on early extinguishment of debt     -             (1,193 )           (1,193 )
    Loss before income taxes     (2,409 )     (2,256 )     (4,500 )     (3,043 )     (12,208 )
    Income taxes     (2 )                       (2 )
    Net loss   $ (2,411 )   $ (2,256 )   $ (4,500 )   $ (3,043 )   $ (12,210 )
    Basic and diluted net loss per common share   $ -0.22     $ -0.15     $ -0.28     $ -0.18     $ -0.83  
    Weighted average shares used in computing basic and diluted net loss per common share     11,105,854       15,241,904       16,035,861       16,542,717       14,736,651